Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay R Lieberman

Showing results (281-290 of 306) with videos related to

Pageof 31
Sort By:
Bioengineering (Basel, Switzerland)|January 24, 2025
<i>Ex Vivo</i> Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing StudyArijita Sarkar, Matthew C Gallo, Jennifer A Bell, et al.
Tissue Engineering. Part A|April 22, 2021
Regional Gene Therapy with Transduced Human Cells: The Influence of "Cell Dose" on Bone RepairHansel Ihn, Hyunwoo Kang, Brenda Iglesias, et al.
Journal of Biomedical Materials Research. Part A|April 11, 2024
In vivo effects of cell seeding technique in an ex vivo regional gene therapy model for bone regenerationJennifer A Bell, Cory K Mayfield, Kevin Collon, et al.
The Journal of Arthroplasty|June 9, 2023
Refining the Role of Routine Synovial Alpha-Defensin in Periprosthetic Joint Infection Following Total Knee Arthroplasty: An Analysis of LimitationsNathanael D Heckmann, Jennifer C Wang, Kevin C Liu, et al.
Connective Tissue Research|July 13, 2026
Combination ex vivo regional gene therapy with sonic hedgehog and bone morphogenetic protein-2 does not enhance bone healing in critical size defectsCory K Mayfield, Julian Wier, Jacob R Ball, et al.
Annals of Internal Medicine|October 16, 2002
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trialCharles W Francis, Bruce L Davidson, Scott D Berkowitz, et al.
Arthroplasty Today|March 5, 2024
An Updated Estimate of Total Hip and Total Knee Arthroplasty Inpatient Case Volume During the 2020 COVID-19 Pandemic in the United StatesNathanael D Heckmann, Cory K Mayfield, Mary K Richardson, et al.
The Journal of Bone and Joint Surgery. American Volume|March 11, 2022
Elective Inpatient Total Joint Arthroplasty Case Volume in the United States in 2020: Effects of the COVID-19 PandemicNathanael D Heckmann, Gabriel J Bouz, Amit S Piple, et al.
The Journal of Arthroplasty|February 8, 2023
The Persistent Effects of the COVID-19 Pandemic on Total Joint Arthroplasty Changes in Practice Patterns in the United States From 2020 to 2021Amit S Piple, Jennifer C Wang, Gabriel J Bouz, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Testing of a Risk-Standardized Major Bleeding and Venous Thromboembolism Electronic Clinical Quality Measure for Elective Total Hip and/or Knee ArthroplastiesTroy Li, Mica Curtin-Bowen, Avery Pullman, et al.
Pageof 31

Showing results (281-290 of 306) with videos related to

Sort By:
Pageof 31
Bioengineering (Basel, Switzerland)|January 24, 2025
<i>Ex Vivo</i> Regional Gene Therapy Compared to Recombinant BMP-2 for the Treatment of Critical-Size Bone Defects: An In Vivo Single-Cell RNA-Sequencing StudyArijita Sarkar, Matthew C Gallo, Jennifer A Bell, et al.
Tissue Engineering. Part A|April 22, 2021
Regional Gene Therapy with Transduced Human Cells: The Influence of "Cell Dose" on Bone RepairHansel Ihn, Hyunwoo Kang, Brenda Iglesias, et al.
Journal of Biomedical Materials Research. Part A|April 11, 2024
In vivo effects of cell seeding technique in an ex vivo regional gene therapy model for bone regenerationJennifer A Bell, Cory K Mayfield, Kevin Collon, et al.
The Journal of Arthroplasty|June 9, 2023
Refining the Role of Routine Synovial Alpha-Defensin in Periprosthetic Joint Infection Following Total Knee Arthroplasty: An Analysis of LimitationsNathanael D Heckmann, Jennifer C Wang, Kevin C Liu, et al.
Connective Tissue Research|July 13, 2026
Combination ex vivo regional gene therapy with sonic hedgehog and bone morphogenetic protein-2 does not enhance bone healing in critical size defectsCory K Mayfield, Julian Wier, Jacob R Ball, et al.
Annals of Internal Medicine|October 16, 2002
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trialCharles W Francis, Bruce L Davidson, Scott D Berkowitz, et al.
Arthroplasty Today|March 5, 2024
An Updated Estimate of Total Hip and Total Knee Arthroplasty Inpatient Case Volume During the 2020 COVID-19 Pandemic in the United StatesNathanael D Heckmann, Cory K Mayfield, Mary K Richardson, et al.
The Journal of Bone and Joint Surgery. American Volume|March 11, 2022
Elective Inpatient Total Joint Arthroplasty Case Volume in the United States in 2020: Effects of the COVID-19 PandemicNathanael D Heckmann, Gabriel J Bouz, Amit S Piple, et al.
The Journal of Arthroplasty|February 8, 2023
The Persistent Effects of the COVID-19 Pandemic on Total Joint Arthroplasty Changes in Practice Patterns in the United States From 2020 to 2021Amit S Piple, Jennifer C Wang, Gabriel J Bouz, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 21, 2022
Testing of a Risk-Standardized Major Bleeding and Venous Thromboembolism Electronic Clinical Quality Measure for Elective Total Hip and/or Knee ArthroplastiesTroy Li, Mica Curtin-Bowen, Avery Pullman, et al.
Pageof 31